54
In band
Moving averages
SMA 200$1.35-52.31%
Company profile
BeyondSpring Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology cancer therapies. The company is headquartered in New York, New York.
SectorHealthcare
IndustryBiotechnology
Market cap$25.49M
P/E ratioNone
EPS$-0.18
Beta-0.207
Dividend yield0.00%
52-week high$2.44
52-week low$0.57
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 41
VRTX
Vertex Pharmaceuticals Inc
RSI 68
CRSP
CRISPR Therapeutics AG
RSI 48
IOVA
Iovance Biotherapeutics Inc
RSI 30
BCTX
BriaCell Therapeutics Corp - New
RSI 31
BCDA
BioCardia Inc
RSI 38
KTTA
Pasithea Therapeutics Corp
RSI 34
CRBU
Caribou Biosciences Inc
RSI 23
IBIO
iBio Inc
RSI 35
PHIO
Phio Pharmaceuticals Corp
RSI 37
RSI alerts for BYSI
An email when BYSI closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 13 October 2026 at 10:09 PM EDT